title: Primary pure squamous cell carcinoma of the endometrium: a case report.
abstract: Because primary pure squamous cell carcinoma (SCC) of the endometrium is very rare and its frequency is unknown, the author reviewed 142 archival hysterectomy specimens of endometrial cancers. As the results, one case of primary pure SCC was found. Thus, the frequency of SCC of the endometrium was 0.7% of all endometrial malignancies in our institution. The patient was a 72-year-old woman presenting with uterine bleeding. Uterine curettage biopsy and uterine discharge cytology revealed SCC. No malignancy was seen in cervical biopsy. Radical hysterectomy, bilateral salpingo-oophorectomy, omentectomy and lymph node dissection were performed. The endometrial carcinoma was an infiltrative polypoid tumor composed of non-keratinizing SCC with stratification and intercellular bridges. No adenocarcinoma element was recognized. The SCC cells were immunohistochemically positive for p53 protein and showed high Ki-67 antigen (labeling, 70%). The SCC was found to invade into the deeper third of the myometrium. No tumor cells were seen in other sites including the cervix, ovaries, omentum, and lymph nodes. The patients was FIGO stage IC (pT1C, N0, M0), and was treated with radiation and adjuvant chemotherapy. The patient is now alive without recurrence and metastasis 15 months after the operation.
authors: Department of Pathology, Shizuoka City Shimizu Hospital, Shizuoka, Japan. piyo0111jp@yahoo.co.jp
authors: Tadashi
authors: T
authors: Terada
authors: Kazuhiro
authors: K
authors: Tateoka
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D016889:Endometrial Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D011878:Radiotherapy
chemical_list: D014408:Biomarkers, Tumor
keywords: Endometrium; histopathology; squamous cell carcinoma
references: Eur J Gynaecol Oncol. 2001;22(2):143-6
references: 11446480
references: Arch Gynecol Obstet. 2008 Aug;278(2):177-80
references: 18236059
references: Int J Gynecol Pathol. 1995 Jan;14(1):75-80
references: 7883431
references: Eur J Gynaecol Oncol. 2008;29(5):527-30
references: 19051828
references: Pathol Int. 2004 Feb;54(2):116-23
references: 14720143
references: Gynecol Oncol. 1996 Apr;61(1):54-60
references: 8626118
references: Tohoku J Exp Med. 2005 Jul;206(3):271-5
references: 15942157
references: Pathol Int. 2009 Jan;59(1):53-8
references: 19121093
references: Gynecol Oncol. 1995 Oct;59(1):117-23
references: 7557596
references: Gynecol Oncol. 1997 Apr;65(1):180-4
references: 9103411
references: Gynecol Oncol. 2003 Mar;88(3):444-6
references: 12648601
references: Gynecol Oncol. 1995 Mar;56(3):464-9
references: 7705688
references: Int J Gynecol Pathol. 2009 Jan;28(1):29-34
references: 19047911
references: Med Oncol. 2009;26(2):233-7
references: 18777214
references: Pathol Int. 2002 Nov;52(11):740-6
references: 12685552
references: Pathol Int. 2003 Nov;53(11):790-5
references: 14629305
references: Gynecol Oncol. 2005 Mar;96(3):876-9
references: 15721443
references: Pathol Int. 2008 Dec;58(12):806-9
references: 19067858
references: Pathol Int. 2008 Dec;58(12):801-5
references: 19067857